- Report
- March 2024
- 146 Pages
Global
From €3749EUR$3,899USD£3,216GBP
- Report
- November 2023
- 146 Pages
Global
From €2403EUR$2,499USD£2,061GBP
- Report
- January 2024
- 220 Pages
Global
From €2394EUR$2,490USD£2,054GBP
- Report
- November 2023
- 190 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- November 2023
- 189 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- October 2023
- 190 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- October 2023
- 181 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- February 2024
- 200 Pages
Global
From €4663EUR$4,850USD£4,001GBP
- Report
- November 2023
- 181 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- October 2023
- 188 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- April 2024
- 165 Pages
Global
From €2404EUR$2,500USD£2,062GBP
- Report
- November 2023
- 163 Pages
Global
From €2404EUR$2,500USD£2,062GBP
- Report
- October 2023
- 188 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- July 2023
- 110 Pages
Global
From €4327EUR$4,500USD£3,712GBP
- Report
- February 2024
- 130 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- January 2024
- 145 Pages
Global
From €4087EUR$4,250USD£3,506GBP
- Report
- September 2023
- 143 Pages
Global
From €4279EUR$4,450USD£3,671GBP
- Report
- March 2024
- 200 Pages
Global
From €3990EUR$4,150USD£3,423GBP
- Report
- March 2024
- 200 Pages
Global
From €3990EUR$4,150USD£3,423GBP
- Report
- February 2024
- 322 Pages
Global
From €3462EUR$3,600USD£2,970GBP
The Respiratory Disease market within the context of Pulmonary Medicine is a broad field of study that focuses on the diagnosis, treatment, and prevention of diseases that affect the lungs and airways. This includes conditions such as asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, and pulmonary hypertension. Treatment options for these conditions range from lifestyle modifications to medications, and in some cases, surgery. Research in this field is ongoing, with the aim of improving the quality of life for those affected by respiratory diseases.
Companies in the Respiratory Disease market include AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck, Novartis, and Pfizer. These companies are involved in the development of new treatments and therapies for respiratory diseases, as well as the manufacture and distribution of existing treatments. Show Less Read more